cardiovasculaire monitoring Cardiac Output Circulating Blood Volume
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: have an age of 18 years or older have signed informed consent be health, demonstrated by the use of apre-operative anesthesiology questionnaire
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: any contraindication to multiple injections of 10 ml cold (approx 4 degrees Celsius) 0.9 % saline intravenously any contraindication to position a sensor nasally (for 15 minutes) incapable of understanding the language in which the information is given.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary hypotheses to be tested are: (1) a reproducible 1st thermal IDC, (2) at least 1 recirculation thermal IDC can be measured with the FBG photonic sensor in both the peripheral and nasal position after a single injection of 10 ml cold (approx 4 degrees Celsius) 0.9 % saline intravenously. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary hypotheses to be tested are: - there is a linear correlation between (the change) of the area under the curve of the primary thermal IDC measured by the FBG photonic sensor, with the change of the Stroke Volume and Cardiac Output measured by a validated non-invasive measurement in three positions of the Tilt-Table Test; - when there is an impact of external temperature differences (of inhaled air) on the thermal IDC measured by the FBG photonic sensor, respiratory and pulse rate signals can be derived from the 1st thermal IDC measured by the FBG photonic sensor; - when there is an impact of external temperature differences (of inhaled air) on the thermal IDC measured by the FBG photonic sensor, respiratory and pulse rate signals can be derived from the 1st thermal IDC measured by the FBG photonic sensor; | — |
Countries
Netherlands